# Intelligent Bio Solutions (INBS) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/INBS
## Company Profile
- Ticker: INBS
- Exchange: NASDAQ
- Sector: MedTech
- Location: United States
- Tags: Diagnostics
## Stock Data
- Close: 2.23 USD
- Market cap: 6075288.84 USD
- Last updated: 2026-09-04
## Business Overview
Intelligent Bio Solutions is a diagnostics company focused on rapid biosensor testing and point-of-care identification. Its business centers on using sensor technology to improve screening and clinical workflows.
## Why The Stock Is Moving

As of Sep 4, 2026, INBS closed down 3.04% at $2.23. No new same-company headline was identified in the current news window.

## Geographic Base

Intelligent Bio Solutions is headquartered in the United States and listed on NASDAQ. It sits in diagnostics and medical devices rather than biotechnology therapeutics.

## Business Model

The company depends on product adoption, commercialization, and the ability to expand its testing platform across use cases. Investors usually watch device rollout, adoption, and revenue growth.

## Landscape Position

Intelligent Bio Solutions is part of the diagnostics and biosensor infrastructure layer. It is not biotech, but it is relevant to the broader testing ecosystem.

## Future Catalysts

- Intelligent Bio Solutions’ catalysts are drug-testing and workplace-safety products, plus any commercial update that clarifies adoption. The story is about product utilization and recurring demand.

## Recent News
- 2026-09-01 12:31 EST — [Intelligent Bio Solutions Achieves Above 98% Accuracy in Method Comparison Study, Supporting Planned 2026 FDA 510(k) Submission](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-achieves-above-98-accuracy-in-method-comparison-study--03c9a529) — Source: Intelligent Bio Solutions
- 2026-09-01 12:30 EST — [Intelligent Bio Solutions Announces Private Placement of up to $15 Million to a Single Existing Institutional Investor Priced At-the-Market Under Nasdaq Rules](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-announces-private-placement-of-up-to-15-million-to-a-s-f2d68af0) — Source: Intelligent Bio Solutions
- 2026-08-19 12:30 EST — [Intelligent Bio Solutions Reports Fiscal 2026 Full-Year Revenue Growth of 38% Year-over-Year, Driven by Reader Installed Base and High-Margin Cartridge Growth](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-reports-fiscal-2026-full-year-revenue-growth-of-38-yea-fbc9f088) — Source: Intelligent Bio Solutions
- 2026-08-17 12:30 EST — [Intelligent Bio Solutions Strengthens Quality Management Credentials with ISO Recertification](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-strengthens-quality-management-credentials-with-iso-re-26b08a12) — Source: Intelligent Bio Solutions
- 2026-08-11 12:30 EST — [Intelligent Bio Solutions Announces Completion of Method Comparison Study for the Intelligent Fingerprinting Drug Screening System](https://biopharmsignal.com/news/INBS/intelligent-bio-solutions-announces-completion-of-method-comparison-study-for-th-12d1c8c9) — Source: Intelligent Bio Solutions